Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hald

Showing results (1091-1100 of 1,101) with videos related to

Pageof 111
Sort By:
Clinical Immunology (Orlando, Fla.)|August 8, 2024
Deep immune cell phenotyping and induced immune cell responses at admission stratified by BMI in patients hospitalized with COVID-19: An observational multicenter cohort pilot studyAdin Sejdic, Hans Jakob Hartling, Jon Gitz Holler, et al.
Nature Communications|March 10, 2019
Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewageRene S Hendriksen, Patrick Munk, Patrick Njage, et al.
JAMA Neurology|March 3, 2025
Location and Timing of Recurrent, Nontraumatic Intracerebral HemorrhageMartina B Goeldlin, Simon Fandler-Höfler, Alessandro Pezzini, et al.
Molecular Metabolism|January 9, 2018
The EndoC-βH1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidatesVioleta Georgieva Tsonkova, Fredrik Wolfhagen Sand, Xenia Asbæk Wolf, et al.
Calcified Tissue International|November 8, 2025
Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis ImperfectaJannie Dahl Hald, Christopher Weir, Catriona Keerie, et al.
American Heart Journal|October 11, 2020
The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT)Henrik Wiggers, Lars Køber, Gunnar Gislason, et al.
JAMA|May 14, 2026
Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: A Randomized Clinical TrialJannie Dahl Hald, Christopher J Weir, Catriona Keerie, et al.
Nature Genetics|July 15, 2009
A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic strokeDaniel F Gudbjartsson, Hilma Holm, Solveig Gretarsdottir, et al.
Journal of Hematology & Oncology|January 13, 2025
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transitionAntonino Glaviano, Hannah Si-Hui Lau, Lukas M Carter, et al.
Trends in Endocrinology and Metabolism: TEM|March 29, 2024
A perspective on muscle phenotyping in musculoskeletal researchInes Foessl, Cheryl L Ackert-Bicknell, Erika Kague, et al.
Pageof 111

Showing results (1091-1100 of 1,101) with videos related to

Sort By:
Pageof 111
Clinical Immunology (Orlando, Fla.)|August 8, 2024
Deep immune cell phenotyping and induced immune cell responses at admission stratified by BMI in patients hospitalized with COVID-19: An observational multicenter cohort pilot studyAdin Sejdic, Hans Jakob Hartling, Jon Gitz Holler, et al.
Nature Communications|March 10, 2019
Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewageRene S Hendriksen, Patrick Munk, Patrick Njage, et al.
JAMA Neurology|March 3, 2025
Location and Timing of Recurrent, Nontraumatic Intracerebral HemorrhageMartina B Goeldlin, Simon Fandler-Höfler, Alessandro Pezzini, et al.
Molecular Metabolism|January 9, 2018
The EndoC-βH1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidatesVioleta Georgieva Tsonkova, Fredrik Wolfhagen Sand, Xenia Asbæk Wolf, et al.
Calcified Tissue International|November 8, 2025
Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis ImperfectaJannie Dahl Hald, Christopher Weir, Catriona Keerie, et al.
American Heart Journal|October 11, 2020
The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT)Henrik Wiggers, Lars Køber, Gunnar Gislason, et al.
JAMA|May 14, 2026
Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: A Randomized Clinical TrialJannie Dahl Hald, Christopher J Weir, Catriona Keerie, et al.
Nature Genetics|July 15, 2009
A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic strokeDaniel F Gudbjartsson, Hilma Holm, Solveig Gretarsdottir, et al.
Journal of Hematology & Oncology|January 13, 2025
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transitionAntonino Glaviano, Hannah Si-Hui Lau, Lukas M Carter, et al.
Trends in Endocrinology and Metabolism: TEM|March 29, 2024
A perspective on muscle phenotyping in musculoskeletal researchInes Foessl, Cheryl L Ackert-Bicknell, Erika Kague, et al.
Pageof 111